Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-23

FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

FDA approved a supplemental application for buprenorphine from Rhodes Pharmaceuticals L.P., indicating regulatory action on an existing product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)